{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"30.000","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"110,781,920","primaryexch":"香港交易所","ric":"2315.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0843,"inline_upper_strike_price":"","sedol":"BNDWR68","am":"20.78","iv":"","ew_strike":"","as":"28.600","geographic_focus":null,"incorpin":"中華人民共和國","etp_baseCur":null,"ew_amt_os":"","bd":"28.400","registrar":"卓佳證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"500","update_time":"2025-09-28 00:06:03.0","lo52":"5.600","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"K","base_currency":null,"coupon":"","expiry_date":"","chairman":"沈月雷","underlying_ric":"2315.HK","hi52":"31.340","issuer_name":"百奧賽圖（北京）醫藥科技股份有限公司 - B - H股","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"28.280","mkt_cap":"3.16","f_aum_hkd":null,"ew_sub_per_to":"","ls":"28.600","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"-0.900","aum":"","issued_shares_class_B":null,"vo":"718.00","secondary_listing_flag":false,"listing_date":"2022年9月1日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"百奧賽圖（北京）醫藥科技股份有限公司 - B - H股","nm_s":"百奧賽圖－Ｂ","sym":"2315","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.020","strike_price":"","summary":"百奧賽圖（北京）醫藥科技股份有限公司是一家主要從事藥物開發業務及臨床前研究的公司。該公司通過五個分部開展業務。基因編輯服務分部提供基於動物和細胞的定制化基因編輯服務。臨床前藥理藥效評估分部提供用於藥物療效和毒性評估的臨床前藥理學服務。模式動物銷售分部培育和銷售外用和內用模式動物。抗體開發分部利用抗體發現平台識別有可能成為候選藥物的抗體。創新藥開發分部研發創新藥，專注腫瘤學和自身免疫性疾病治療。","op":"29.540","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"生物技術","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"中國<br/>北京市大興區<br/>大興生物醫藥產業基地<br/>寶參南街12號院","pc":"-3.05","days_to_expiry":null,"underlying_code":null,"pe":"320.63","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"29.500","isin":"CNE100005D27","moneyness":""}},"qid":"1759074314215"}
